Institutional investors purchased a net $26.9 thousand shares of JNP during the quarter ended December 2015 and now own 34.85% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARGENTA BANQUE D'EPARGNE SA Bought 6.9 Thousand shares of Juniper Pharmaceuticals I...